Valby, Denmark

Mario Rottländer

This inventor holds 2 USPTO granted patents. Top assignee: H. Lundbeck A/s. Active years: 2002-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mario Rottländer. Retrieved from https://idiyas.com/inventor/mario-rottlandaumlnder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Mario Rottländer

Introduction

Mario Rottländer is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 2 patents to his name, Rottländer's work has the potential to impact various therapeutic areas.

Latest Patents

Rottländer's latest patents include "Substituted phenyl-piperazine derivatives, their preparation and use" and "Benzofuran derivatives, their preparation and use." These innovations reflect his commitment to advancing medicinal chemistry and improving drug efficacy.

Career Highlights

Mario Rottländer is currently employed at H. Lundbeck A/S, a leading global pharmaceutical company. His role involves research and development, where he focuses on creating new therapeutic solutions. His expertise in medicinal chemistry has been instrumental in the company's innovative projects.

Collaborations

Rottländer has collaborated with talented colleagues such as Thomas Ruhland and Kim Andersen. These partnerships have fostered a creative environment that encourages the exchange of ideas and enhances the research process.

Conclusion

Mario Rottländer's contributions to the field of pharmaceuticals through his patents and collaborations highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to inspire advancements in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…